KIYATEC

Greenville, United States

KIYATEC utilizes the patient's own living tumor cells to create functional 3D models to test a battery of cancer therapies.

$18.0M raised

May 2023

Series C

Top Investors

LabCorpBrukerSeae VenturesVentureSouthBrain Tumor Investment Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has KIYATEC raised?

KIYATEC has raised $18.0M in total funding. The most recent round was Series C. The last funding was announced in May 2023.

Who are KIYATEC's investors?

KIYATEC's investors include LabCorp, Bruker, Seae Ventures, VentureSouth, Brain Tumor Investment Fund.

Where is KIYATEC headquartered?

KIYATEC is headquartered in Greenville, United States.

What does KIYATEC do?

KIYATEC utilizes the patient's own living tumor cells to create functional 3D models to test a battery of cancer therapies.

What stage is KIYATEC at?

KIYATEC is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 18, 2023.

MLA

"KIYATEC — Funding & Investors." VCBacked, May 18, 2023, https://www.vcbacked.co/company/kiyatec. Accessed June 10, 2026.

APA

VCBacked. (2023). KIYATEC — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/kiyatec

Wikipedia (cite web)

{{cite web |title=KIYATEC — Funding & Investors |url=https://www.vcbacked.co/company/kiyatec |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 18, 2023.